{"name": "Combinature Biopharm",
 "permalink": "combinature-biopharm",
 "crunchbase_url": "http://www.crunchbase.com/company/combinature-biopharm",
 "homepage_url": "",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2000,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "49-30-9489-4050",
 "description": "",
 "created_at": "Tue Apr 27 08:41:48 UTC 2010",
 "updated_at": "Tue Apr 27 08:49:24 UTC 2010",
 "overview": "\u003Cp\u003ECombinature Biopharm is a drug discovery and development company, which uses a genomics and robotics driven technology platform to discover enzymes and the respective genes. The company\u00e2\u20ac\u2122s products are used for biocatalysis applications and in-house in throughput combinatorial biosynthesis program aimed at generating natural compounds. The company has strategic partnerships with Aventis, Degussa, DSM, Novazymes, and PSF Biotech AG. Combinature Biopharm is based in Berlin, Germany. As of August 21, 2006, Combinature Biopharm is a subsidiary of MerLion Pharmaceuticals Pte Ltd.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$5.11M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 5110000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 5,
    "funded_day": 8,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Aurelia Private Equity",
         "permalink": "aurelia-private-equity",
         "image":
          {"available_sizes":
            [[[150,
               83],
              "assets/images/resized/0008/5055/85055v1-max-150x150.jpg"],
             [[185,
               103],
              "assets/images/resized/0008/5055/85055v1-max-250x250.jpg"],
             [[185,
               103],
              "assets/images/resized/0008/5055/85055v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "3i Group",
         "permalink": "3i-group",
         "image":
          {"available_sizes":
            [[[70,
               68],
              "assets/images/resized/0001/9740/19740v1-max-150x150.png"],
             [[70,
               68],
              "assets/images/resized/0001/9740/19740v1-max-250x250.png"],
             [[70,
               68],
              "assets/images/resized/0001/9740/19740v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BC Brandenburg Capital",
         "permalink": "bc-brandenburg-capital",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0002/2957/22957v2-max-150x150.png"],
             [[250,
               71],
              "assets/images/resized/0002/2957/22957v2-max-250x250.png"],
             [[251,
               72],
              "assets/images/resized/0002/2957/22957v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Robert-R\u00c3\u00b6ssle-Street 10",
    "address2": "",
    "zip_code": "13125",
    "city": "Berlin",
    "state_code": null,
    "country_code": "DEU",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}